Thorpe et al. then moved onto investigation of endogenous targets, of which the first was vascular cell adhesion molecule 1 (VCAM-1/CD106), a cytokine-inducible inflammatory surface molecule expressed by the tumor vasculature and some tumor cells. The gene discussed is VCAM1; the disease is neoplasm.